Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
Systemic lupus erythematosus is a complex autoimmune disease in which more than one-third of patients develop lupus nephritis (LN), leading to chronic kidney disease and end-stage renal failure. The treatment of LN has always been a challenge. Tacrolimus is an effective immunosuppressant that has be...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2025-06-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1784 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849242046397677568 |
|---|---|
| author | N. Yu. Nikishina E. A. Aseeva S. K. Soloviev A. M. Lila A. V. Datcina E. T. Pletnev |
| author_facet | N. Yu. Nikishina E. A. Aseeva S. K. Soloviev A. M. Lila A. V. Datcina E. T. Pletnev |
| author_sort | N. Yu. Nikishina |
| collection | DOAJ |
| description | Systemic lupus erythematosus is a complex autoimmune disease in which more than one-third of patients develop lupus nephritis (LN), leading to chronic kidney disease and end-stage renal failure. The treatment of LN has always been a challenge. Tacrolimus is an effective immunosuppressant that has been increasingly used in recent years for the treatment of LN. |
| format | Article |
| id | doaj-art-5508789c7fcd41c5adb1aba20b8271f7 |
| institution | Kabale University |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2025-06-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-5508789c7fcd41c5adb1aba20b8271f72025-08-20T03:59:56ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2025-06-0119311512010.14412/1996-7012-2025-3-115-1202800Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosusN. Yu. Nikishina0E. A. Aseeva1S. K. Soloviev2A. M. Lila3A. V. Datcina4E. T. Pletnev5V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of Rheumatology ; Department of Rheumatology, Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologySystemic lupus erythematosus is a complex autoimmune disease in which more than one-third of patients develop lupus nephritis (LN), leading to chronic kidney disease and end-stage renal failure. The treatment of LN has always been a challenge. Tacrolimus is an effective immunosuppressant that has been increasingly used in recent years for the treatment of LN.https://mrj.ima-press.net/mrj/article/view/1784systemic lupus erythematosuslupus nephritiscalcineurin inhibitors |
| spellingShingle | N. Yu. Nikishina E. A. Aseeva S. K. Soloviev A. M. Lila A. V. Datcina E. T. Pletnev Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus Современная ревматология systemic lupus erythematosus lupus nephritis calcineurin inhibitors |
| title | Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus |
| title_full | Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus |
| title_fullStr | Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus |
| title_full_unstemmed | Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus |
| title_short | Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus |
| title_sort | efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus |
| topic | systemic lupus erythematosus lupus nephritis calcineurin inhibitors |
| url | https://mrj.ima-press.net/mrj/article/view/1784 |
| work_keys_str_mv | AT nyunikishina efficacyandsafetyofcalcineurininhibitorsuseinpatientswithsystemiclupuserythematosus AT eaaseeva efficacyandsafetyofcalcineurininhibitorsuseinpatientswithsystemiclupuserythematosus AT sksoloviev efficacyandsafetyofcalcineurininhibitorsuseinpatientswithsystemiclupuserythematosus AT amlila efficacyandsafetyofcalcineurininhibitorsuseinpatientswithsystemiclupuserythematosus AT avdatcina efficacyandsafetyofcalcineurininhibitorsuseinpatientswithsystemiclupuserythematosus AT etpletnev efficacyandsafetyofcalcineurininhibitorsuseinpatientswithsystemiclupuserythematosus |